On Feb. 5, Aurora Cannabis reported its fiscal third-quarter results for the period ended Dec. 31. The cannabis company ...

As a leader in the medical cannabis space, Aurora Cannabis is enjoying premium margins. Read why I rate ACB stock a Strong ...

Aurora Cannabis has shifted focus to the medical cannabis market, achieving higher gross margins. Read why I upgrade ACB ...

Aurora Cannabis Inc. closed 31.34% below its 52-week high of $9.35, which the company reached on April 30th.

Medical cannabis company Aurora Cannabis (ACB) has surprised markets with a record-breaking third quarter, sending its shares ...

CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical ...

Aurora Cannabis Inc. closed 29.30% below its 52-week high of $9.35, which the company reached on April 30th.

From political maneuvering in Washington to major corporate developments across the global cannabis landscape, this week has ...

Canaccord raised the firm’s price target on Aurora Cannabis (ACB) to C$12.50 from C$10 and keeps a Buy rating on the shares.Maximize Your ...

ACB Agreement Complements Existing Relationship Focused on the Supply of Premium CannabisEDMONTON, AB, February 6, 2 ...

This news release includes statements containing certain "forward-looking information" within the meaning of applicable securities law ("forward-looking statements"). Forward-looking statements ...